Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000912282-09-000734
Filing Date
2009-05-18
Accepted
2009-05-18 14:47:40
Documents
5
Period of Report
2009-05-15

Document Format Files

Seq Description Document Type Size
1 oncolytics6k_05152009.htm 6-K 8103
2 UNDERWRITING AGREEMENT ex99_1.htm EX-99.1 265368
3 WARRANT INDENTURE ex99_2.htm EX-99.2 392683
4 GRAPHIC toc_pg1.jpg GRAPHIC 217997
5 GRAPHIC toc_pg2.jpg GRAPHIC 215903
  Complete submission text file 0000912282-09-000734.txt   1265670
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 09836422
SIC: 2834 Pharmaceutical Preparations